The impact of indacaterol/glycopyrronium fixed-dose combination versus tiotropium monotherapy on lung function and treatment preference: a randomized crossover study – the FAVOR study

Peter Kardos,1 Ina Hagedorn-Peinz2 1Pulmonary Department, Respiratory and Sleep Medicine at Red Cross Maingau Hospital, Group Practice Allergy, Frankfurt, Germany; 2Novartis Pharma GmbH, Nuremberg, Germany Background: The objective of the FAVOR study was to evaluate the effect of indacaterol/glyco...

Description complète

Détails bibliographiques

Auteurs principaux:	Kardos P, Hagedorn-Peinz I
Format:	Artigo
Langue:	Inglês
Publié:	Dove Medical Press 2017-12-01
Collection:	International Journal of COPD
Sujets:	COPD dual-bronchodilators FEV1 indacaterol/glycopyrronium treatment preference treatment satisfaction
Accès en ligne:	https://www.dovepress.com/the-impact-of-indacaterolglycopyrronium-fixed-dose-combination-versus--peer-reviewed-article-COPD
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!